James Bradner
About James Bradner
James Bradner is the Executive Vice President of Research and Development and Chief Scientific Officer, previously serving as president of the Novartis Institutes for BioMedical Research.
Executive Vice President, Research and Development, and Chief Scientific Officer
James Bradner currently holds the position of Executive Vice President, Research and Development, and Chief Scientific Officer. In this role, he oversees the company’s research and development initiatives, focusing on advancing scientific discoveries and creating impactful solutions in the biomedical field. His responsibilities include leading R&D teams, coordinating strategic scientific projects, and ensuring that innovative therapies are developed effectively.
President of the Novartis Institutes for BioMedical Research
Before his current role, James Bradner served as the president of the Novartis Institutes for BioMedical Research. During his tenure, he was responsible for steering the organization’s research strategies and fostering collaboration among scientists to drive biomedical innovations. His leadership contributed to the development of new therapeutic approaches and the furthering of medical research.
Faculty Member at Harvard Medical School
James Bradner has served as a faculty member at Harvard Medical School. In this academic capacity, he was involved in teaching, mentoring, and conducting research. His work at Harvard Medical School allowed him to contribute to the education of future medical professionals while advancing research in his areas of expertise.
Practicing Oncologist at Dana-Farber Cancer Institute
James Bradner was a practicing oncologist at the Dana-Farber Cancer Institute. As a clinician, he provided medical care to cancer patients and participated in developing treatment protocols. His practical experience in oncology complemented his research efforts and provided valuable insights into patient care and the effectiveness of new treatments.